MedPath

Prospective observational study on cytokine removal in continuous hemodiafiltratio

Not Applicable
Recruiting
Conditions
Patients who started continuous hemodiafiltration
Registration Number
JPRN-UMIN000040565
Lead Sponsor
Juntendo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who the investigator determined to be inappropriate as subjects (Patients who deviate from the dialysis conditions [dialysis fluid 0.4 L / hour, replacement fluid 0.4 L / hour], who also use endotoxin adsorption therapy, who need to change the purification membrane within 24 hours of CHDF start, and within 24 hours. Those who have completed CHDF)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath